-
1
-
-
0031003125
-
Management of canine pituitary-dependent hyperadrenocorticism with I-deprenyl (Anipryl)
-
Bruyette DS, Ruehl WW, Entriken T, Griffin D, Darling L. Management of canine pituitary-dependent hyperadrenocorticism with I-deprenyl (Anipryl). Vet Clin N Am 1997;27:273-286.
-
(1997)
Vet Clin N Am
, vol.27
, pp. 273-286
-
-
Bruyette, D.S.1
Ruehl, W.W.2
Entriken, T.3
Griffin, D.4
Darling, L.5
-
2
-
-
0002292045
-
Treating canine pituitary-dependent hyperadrenocorticism with L-deprenyl
-
Bruyette DS, Ruehl WW, Entriken TL, Darling LA, Griffin DW. Treating canine pituitary-dependent hyperadrenocorticism with L-deprenyl. Vet Med 1997;92:711-727.
-
(1997)
Vet Med
, vol.92
, pp. 711-727
-
-
Bruyette, D.S.1
Ruehl, W.W.2
Entriken, T.L.3
Darling, L.A.4
Griffin, D.W.5
-
4
-
-
0002601508
-
A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting
-
Campbell S, Trettien A, Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Ther 2001;2:24-39.
-
(2001)
Vet Ther
, vol.2
, pp. 24-39
-
-
Campbell, S.1
Trettien, A.2
Kozan, B.3
-
5
-
-
0019423783
-
Pituitary intermediate lobe in dogs: Two cell types and high bioactive adrenocorticotropin content
-
Halmi NS, Peterson ME, Colurso GJ, Liotta AS, Krieger DT. Pituitary intermediate lobe in dogs: two cell types and high bioactive adrenocorticotropin content. Science 1981;211:72-74.
-
(1981)
Science
, vol.211
, pp. 72-74
-
-
Halmi, N.S.1
Peterson, M.E.2
Colurso, G.J.3
Liotta, A.S.4
Krieger, D.T.5
-
6
-
-
0023025413
-
In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe
-
Kemppainen RJ, Sartin JL. In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. Acta Endocrinol 1986;113:471-473.
-
(1986)
Acta Endocrinol
, vol.113
, pp. 471-473
-
-
Kemppainen, R.J.1
Sartin, J.L.2
-
7
-
-
0024523727
-
Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells
-
Kemppainen RJ, Zerbe CA, Sartin JL. Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells. Endocrinology 1989;124:2208-2217.
-
(1989)
Endocrinology
, vol.124
, pp. 2208-2217
-
-
Kemppainen, R.J.1
Zerbe, C.A.2
Sartin, J.L.3
-
8
-
-
0002712702
-
Adrenals
-
Rijnberk A, editor. Kluwer Academic Publishers, Dordrecht
-
Rijnberk A. Adrenals. In: Rijnberk A, editor. Clinical endocrinology of dogs and cats. Kluwer Academic Publishers, Dordrecht, 1996:61-93.
-
(1996)
Clinical Endocrinology of Dogs and Cats
, pp. 61-93
-
-
Rijnberk, A.1
-
9
-
-
0022498183
-
Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: Basal concentrations
-
Peterson ME, Orth DN, Halmi NS et al. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations. Endocrinology 1986;119:720-730.
-
(1986)
Endocrinology
, vol.119
, pp. 720-730
-
-
Peterson, M.E.1
Orth, D.N.2
Halmi, N.S.3
-
10
-
-
0022362884
-
Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe
-
Antakly T, Sasaki A, Liotta AS, Palkovits M, Krieger DT. Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe. Science 1985;229:277-279.
-
(1985)
Science
, vol.229
, pp. 277-279
-
-
Antakly, T.1
Sasaki, A.2
Liotta, A.S.3
Palkovits, M.4
Krieger, D.T.5
-
11
-
-
0027286710
-
Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary
-
Zerbe CA, Clark TP, Sartin JL, Kemppainen RJ. Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary. Neuroendocrinol 1993;57:282-288
-
(1993)
Neuroendocrinol
, vol.57
, pp. 282-288
-
-
Zerbe, C.A.1
Clark, T.P.2
Sartin, J.L.3
Kemppainen, R.J.4
-
12
-
-
0026092999
-
Distinct classes of corticotropes mediate corticotropin-releasing hormone and arginine vasopressin-stimulated adrenocorticotropin release
-
Jia L, Canny BC, Orth D, Leong DA. Distinct classes of corticotropes mediate corticotropin-releasing hormone and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology 1991;128:197-203
-
(1991)
Endocrinology
, vol.128
, pp. 197-203
-
-
Jia, L.1
Canny, B.C.2
Orth, D.3
Leong, D.A.4
-
13
-
-
0024384162
-
Biogenic amine and corticotropin-releasing factor concentrations in hypothalamic paraventricular nucleus and biogenic amine levels in the median eminence of normal dogs, chronic dexamethasone-treated dogs, and dogs with naturally-occurring pituitary-dependent hyperadrenocorticism (canine Cushing's disease)
-
Peterson ME, Palkovits M, Chiueh CC et al. Biogenic amine and corticotropin-releasing factor concentrations in hypothalamic paraventricular nucleus and biogenic amine levels in the median eminence of normal dogs, chronic dexamethasone-treated dogs, and dogs with naturally-occurring pituitary-dependent hyperadrenocorticism (canine Cushing's disease). J Neuroendocrinol 1989;1:169-171.
-
(1989)
J Neuroendocrinol
, vol.1
, pp. 169-171
-
-
Peterson, M.E.1
Palkovits, M.2
Chiueh, C.C.3
-
14
-
-
0019522821
-
Hypothalamic catecholamine levels in dogs with spontaneous hyperadrenocorticism
-
Meijer JC, Croughs RJM, Rijnberk A, Versteeg DHG, van Ree JM. Hypothalamic catecholamine levels in dogs with spontaneous hyperadrenocorticism. Neuroendocrinol 1981;32:197-201.
-
(1981)
Neuroendocrinol
, vol.32
, pp. 197-201
-
-
Meijer, J.C.1
Croughs, R.J.M.2
Rijnberk, A.3
Versteeg, D.H.G.4
Van Ree, J.M.5
-
16
-
-
0029037575
-
Effects of chronic oral administration of I-deprenyl in the dog
-
Milgram NW, Ivy GO, Murphy MP et al. Effects of chronic oral administration of I-deprenyl in the dog. Pharmacol Biochem Behav 1995;51:421-428.
-
(1995)
Pharmacol Biochem Behav
, vol.51
, pp. 421-428
-
-
Milgram, N.W.1
Ivy, G.O.2
Murphy, M.P.3
-
17
-
-
33751259254
-
The pituitary gland
-
British Small Animal Veterinary Association, Cheltenham
-
Watson ADJ. The pituitary gland. In: Manual of Small Animal Endocrinology. British Small Animal Veterinary Association, Cheltenham, 1990:9-24.
-
(1990)
Manual of Small Animal Endocrinology
, pp. 9-24
-
-
Watson, A.D.J.1
-
18
-
-
0346815328
-
L-deprenyl therapy of canine pituitary-dependent hyperadrenocorticism
-
abstract
-
Bruyette DS, Ruehl WW, Smidberg TL. L-deprenyl therapy of canine pituitary-dependent hyperadrenocorticism [abstract]. J Vet Intern Med 1993;7:114.
-
(1993)
J Vet Intern Med
, vol.7
, pp. 114
-
-
Bruyette, D.S.1
Ruehl, W.W.2
Smidberg, T.L.3
-
19
-
-
11344287927
-
L-Deprenyl for canine pituitary-dependent hyperadrenocorticism: Pivotal efficacy trial
-
[abstract], San Antonio
-
Bruyette DS, Darling LA, Griffin D, Ruehl WW. L-Deprenyl for canine pituitary-dependent hyperadrenocorticism: pivotal efficacy trial [abstract]. Proceedings 14th Annual Medical Forum American College of Veterinary Internal Medicine, San Antonio, 1996:764.
-
(1996)
Proceedings 14th Annual Medical Forum American College of Veterinary Internal Medicine
, pp. 764
-
-
Bruyette, D.S.1
Darling, L.A.2
Griffin, D.3
Ruehl, W.W.4
-
20
-
-
33751292299
-
Effects of chronic treatment with the monoamine oxidase inhibitor (I-deprenyl) on CRH stimulation testing in geriatric beagle dogs
-
abstract
-
Bruyette D, Ruehl W, Muggenburg B. Effects of chronic treatment with the monoamine oxidase inhibitor (I-deprenyl) on CRH stimulation testing in geriatric beagle dogs [abstract]. J Vet Intern Med 1994;8:163.
-
(1994)
J Vet Intern Med
, vol.8
, pp. 163
-
-
Bruyette, D.1
Ruehl, W.2
Muggenburg, B.3
-
21
-
-
0033161326
-
The efficacy of I-deprenyl in dogs with pituitary-dependent hyperadrenocorticism
-
Reusch CE, Steffen T, Hoerauf A. The efficacy of I-deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1999;13: 291-301.
-
(1999)
J Vet Intern Med
, vol.13
, pp. 291-301
-
-
Reusch, C.E.1
Steffen, T.2
Hoerauf, A.3
-
23
-
-
0032038957
-
Plasma cortisol responses to three corticotrophic preparations in normal dogs
-
Watson ADJ, Church DB, Emslie DR, Foster SF. Plasma cortisol responses to three corticotrophic preparations in normal dogs. Aust Vet J 1998;76:255-257.
-
(1998)
Aust Vet J
, vol.76
, pp. 255-257
-
-
Watson, A.D.J.1
Church, D.B.2
Emslie, D.R.3
Foster, S.F.4
-
24
-
-
0027436388
-
Plasma cortisol concentrations in dogs given cortisone or placebo by mouth
-
Watson ADJ, Church DB, Emslie DR. Plasma cortisol concentrations in dogs given cortisone or placebo by mouth. Res Vet Sci 1993;55:379-381.
-
(1993)
Res Vet Sci
, vol.55
, pp. 379-381
-
-
Watson, A.D.J.1
Church, D.B.2
Emslie, D.R.3
-
25
-
-
0027600610
-
Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs
-
Smiley LE, Peterson ME. Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Vet Intern Med 1993;7:163-168.
-
(1993)
J Vet Intern Med
, vol.7
, pp. 163-168
-
-
Smiley, L.E.1
Peterson, M.E.2
-
26
-
-
0025619139
-
Effects of sample handling on adrenocorticotropin concentration measured in canine plasma, using a commercially available radioimmunoassay kit
-
Hegstad RL, Johnston SD, Pasternak DM. Effects of sample handling on adrenocorticotropin concentration measured in canine plasma, using a commercially available radioimmunoassay kit. Am J Vet Res 1990;51:1941-1947.
-
(1990)
Am J Vet Res
, vol.51
, pp. 1941-1947
-
-
Hegstad, R.L.1
Johnston, S.D.2
Pasternak, D.M.3
-
27
-
-
0029564645
-
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia, and Alzheimer's disease: Clinical presentation, cognitive testing, pathology and response to L-deprenyl therapy
-
Ruehl WW, Bruyette DS, DePaoli A et al. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia, and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to L-deprenyl therapy. Prog Brain Res 1995;106:217-225.
-
(1995)
Prog Brain Res
, vol.106
, pp. 217-225
-
-
Ruehl, W.W.1
Bruyette, D.S.2
DePaoli, A.3
-
28
-
-
0030035625
-
Psychiatric aspects of Cushing's syndrome
-
Kelly WF. Psychiatric aspects of Cushing's syndrome. Q J Med 1996;89:543-551
-
(1996)
Q J Med
, vol.89
, pp. 543-551
-
-
Kelly, W.F.1
-
29
-
-
2342467406
-
Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism
-
Braddock, JA, Church DB, Robertson ID, Watson ADJ. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Aust Vet J 2003;81:600-607.
-
(2003)
Aust Vet J
, vol.81
, pp. 600-607
-
-
Braddock, J.A.1
Church, D.B.2
Robertson, I.D.3
Watson, A.D.J.4
|